These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30877621)

  • 41. Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications.
    Masi G; Perugi G; Millepiedi S; Toni C; Mucci M; Pfanner C; Berloffa S; Pari C; Akiskal HS
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):475-86. PubMed ID: 17822342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obsessive-compulsive disorder.
    Leonard HL; Ale CM; Freeman JB; Garcia AM; Ng JS
    Child Adolesc Psychiatr Clin N Am; 2005 Oct; 14(4):727-43, viii. PubMed ID: 16171700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Introduction to obsessive-compulsive disorder].
    Nakamura K; Ushijima S
    Ryoikibetsu Shokogun Shirizu; 2003; (38):430-3. PubMed ID: 12877019
    [No Abstract]   [Full Text] [Related]  

  • 44. [Again and again--the obsessive circle can be broken].
    Rück C; Andersson EM; Andréewitch S; Bejerot S; Ivarsson T; Bates S; Lindefors N
    Lakartidningen; 2011 Apr 6-12; 108(14):798-801. PubMed ID: 21638920
    [No Abstract]   [Full Text] [Related]  

  • 45. [Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].
    Prazeres AM; Souza WF; Fontenelle LF
    Braz J Psychiatry; 2007 Sep; 29(3):262-70. PubMed ID: 17713699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial.
    Tolin DF; Maltby N; Diefenbach GJ; Hannan SE; Worhunsky P
    J Clin Psychiatry; 2004 Jul; 65(7):922-31. PubMed ID: 15291681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skin Picking Successfully Treated With Atomoxetine in Comorbid Skin Picking and Attention-Deficit/Hyperactivity Disorder: A Case Report.
    Yurteri N; Sarıgedik E
    Clin Neuropharmacol; 2020; 43(4):114-115. PubMed ID: 32541332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder].
    Vloet TD; Simons M; Herpertz-Dahlmann B
    Z Kinder Jugendpsychiatr Psychother; 2012 Jan; 40(1):29-39; quiz 39-40. PubMed ID: 22161940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atomoxetine Induced Skin Picking: A Case Report.
    Kasar N; Yurteri N
    Clin Neuropharmacol; 2020; 43(2):46-47. PubMed ID: 32106136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of compulsive hoarding.
    Saxena S; Maidment KM
    J Clin Psychol; 2004 Nov; 60(11):1143-54. PubMed ID: 15389621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    Pediatric OCD Treatment Study (POTS) Team
    JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Supportive psychotherapy, SSRIs, and MDD.
    Hamilton J; Bridge J
    J Am Acad Child Adolesc Psychiatry; 2006 Jan; 45(1):6-7. PubMed ID: 16327576
    [No Abstract]   [Full Text] [Related]  

  • 53. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
    Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dermatillomania: A Case Report and Literature Review.
    Malayala SV; Rehman H; Vasireddy D
    Cureus; 2021 Jan; 13(1):e12932. PubMed ID: 33654612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Obsessive-compulsive disorder in childhood and adolescence].
    Hoshino Y
    Ryoikibetsu Shokogun Shirizu; 2003; (40):106-10. PubMed ID: 14626078
    [No Abstract]   [Full Text] [Related]  

  • 57. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.
    Fineberg NA; Reghunandanan S; Simpson HB; Phillips KA; Richter MA; Matthews K; Stein DJ; Sareen J; Brown A; Sookman D;
    Psychiatry Res; 2015 May; 227(1):114-25. PubMed ID: 25681005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment.
    Arnold LM; Auchenbach MB; McElroy SL
    CNS Drugs; 2001; 15(5):351-9. PubMed ID: 11475941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obsessive-compulsive disorder in Tourette syndrome.
    Goodman WK; Storch EA; Geffken GR; Murphy TK
    J Child Neurol; 2006 Aug; 21(8):704-14. PubMed ID: 16970872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.